Alpha Remedies Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 25-12-2024
- Paid Up Capital ₹ 2.17 Cr
as on 25-12-2024
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.29 Cr
as on 25-12-2024
- Revenue %
(FY 2021)
- Profit -15.91%
(FY 2021)
- Ebitda -10.00%
(FY 2021)
- Net Worth -0.01%
(FY 2021)
- Total Assets -0.00%
(FY 2021)
About Alpha Remedies
The Corporate was formerly known as Alpha Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.17 Cr.
The company currently has active open charges totaling ₹10.29 Cr.
Preetiindersingh Sethi, Atul Barhate, and Rajesh Borkar serve as directors at the Company.
- CIN/LLPIN
U24208MH1988PLC046746
- Company No.
046746
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Mar 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alpha Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preetiindersingh Sethi  | Director | 25-Mar-1988 | Current |
| Atul Barhate | Director | 27-Nov-2017 | Current |
| Rajesh Borkar | Additional Director | 02-May-2024 | Current |
Financial Performance of Alpha Remedies.
Alpha Remedies Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 15.91% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpha Remedies?
In 2021, Alpha Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹10.29 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 5.34 Cr
- State Bank Of India : 4.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 1999 | Bank Of Maharashtra | ₹9.50 M | Open |
| 29 Jun 1998 | State Bank Of India | ₹9.50 M | Open |
| 20 Jun 1998 | Bank Of Maharashtra | ₹1.01 M | Open |
| 31 Mar 1998 | Bank Of Maharashtra | ₹3.00 Cr | Open |
| 03 Dec 1997 | Bank Of Maharashtra | ₹4.00 M | Open |
How Many Employees Work at Alpha Remedies?
Unlock and access historical data on people associated with Alpha Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpha Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpha Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
